Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Bellicum Pharma Comm (NQ: BLCM)
1.920 USD  -0.010 (-0.52%)
Official Closing Price  /  Updated: 4:25 PM EDT, Jun 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 431,800
Open 1.940
Bid (Size) 1.400 (1)
Ask (Size) 3.560 (2)
Prev. Close 1.930
Today's Range 1.850 - 1.980
52wk Range 1.540 - 10.15
Shares Outstanding 42,873,045
Dividend Yield N/A
Performance
YTD
-42.34%
-42.34%
1 Month
-29.15%
-29.15%
3 Month
-46.07%
-46.07%
6 Month
-49.61%
-49.61%
1 Year
-78.64%
-78.64%
Top News
More News
Bellicum Pharmaceuticals Provides Interim Data for BPX-601 in Patients with Metastatic Pancreatic Cancer for Presentation at ASCO Annual Meeting
Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today announced updated safety and... Read More
from GlobeNewswire News Releases
Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) and Encourages Bellicum Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM). Read More
from GlobeNewswire News Releases
More News
Read More
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
from GlobeNewswire News Releases
(BLCM) Alert: Johnson Fistel, LLP Announces Investigation of Bellicum Pharmaceuticals, Inc.; Long Term Investors Encouraged to Contact Firm
from PR Newswire
Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting
from GlobeNewswire News Releases
Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational Update
from GlobeNewswire News Releases
Recent Analysis Shows Dollar General, PACCAR, Bellicum Pharmaceuticals, and Enzo Biochem Market Influences — Renewed Outlook, Key Drivers of Growth
from GlobeNewswire News Releases
Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit
from GlobeNewswire News Releases
NASDAQ:BLCM Investor Notice: Investigation over Potential Wrongdoing by Bellicum Pharmaceuticals Inc
from SBWire - Latest Press Releases
VTI's Underlying Holdings Could Mean 10% Gain Potential
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.